Background/aim: Thiol-disulfide homeostasis is an important antioxidant defense mechanism. This study was conducted to investigate dynamic thiol-disulfide homeostasis in patients with hepatitis B virus-related chronic hepatitis and liver cirrhosis. Materials and methods: Seventy-one treatment-naive patients with chronic hepatitis B (CHB), 50 patients with hepatitis B virus-associated liver cirrhosis, and 45 healthy controls were included in the study. Serum total and native thiol concentrations and serum disulfide concentrations were measured using an automated method. Results: Mean serum total thiol concentrations in the control, CHB, and cirrhosis groups were 481.64 +/- 37.87 mu mol/L, 438.50 +/- 71.35 mu mol/L, and 358.07 +/- 80.47 mu mol/L, respectively (P < 0.001), and mean serum native thiol concentrations in the control, CHB, and cirrhosis groups were 452.92 +/- 36.43 mu mol/L, 400.16 +/- 65.92 mu mol/L, and 328.15 +/- 74.91 mu mol/L, respectively (P < 0.001). Mean serum disulfide concentrations in the control, CHB, and cirrhosis groups were 14.38 +/- 3.38 mu mol/L, 19.19 +/- 6.16 mu mol/L, and 14.98 +/- 5.53 mu mol/L, respectively (P < 0.001). There was a progressive decrease in both mean serum native and total thiol concentrations parallel to the liver fibrosis stage. Conclusion: Thiol-disulfide homeostasis is disturbed in patients with hepatitis B virus-related chronic hepatitis and liver cirrhosis.
24 April 2018 in Akademik Gastroenteroloji Dergisi
Giriş ve Amaç: Gastroözofageal reflü hastalığı üst gastrointestinal kanalın sık rastlanılan bir hastalığıdır. Anatomik lokalizasyonu nedeniyle özofagusa komşuluğu olan organların hastalıklarını taklit edebildiği gibi; asıl hastalığın şikayetini maskeleyebilmekte hatta oluşan komplikasyonları da başka organların fonksiyonlarını bozabilmektedir. Dünyada batı tipi yaşantısı olan toplumlarda daha sık görülmektedir. Türkiye’de hastalık epidemiyolojisi ile sınırlı veri vardır. Gereç ve Yöntem: Yaşadığımız çevrenin prevalansını belirleyebilmek amaçlı yapılan çalışmada Konya İli Merkez İlçelerinde önceden belirlenmiş rastgele adreslerdeki 2000 kişi ile anket görüşmesi yapılmıştır. Bulgular: 1188 kişi ile anket tamamlanabilmiş, (%59 geri dönüş oranı), katılımcıların 581’i kadın (%48.9), 607’si erkek (%51.1), yaş ortalaması 41.34±12.8 olarak hesaplanmıştır. Aylık semptomlar göz önüne alındığında aylık %10,9 prevalans bulunmuştur. Cinsiyet, medeni hal, eğitim düzeyi, meslek ve gelir durumu reflü ile ilişkili bulunmazken yaş ve vücut kitle indeksi ile korelasyon saptanmıştır (p<0.05). Sonuç: Bulunan sonuç itibariyle Konya İli merkez ilçelerinde her üç kişiden birinin kilolu ya da obez olduğu saptanmış, reflü prevalansının batı ülkelerine yakın olduğu görülmüştür.
Aim: We aimed to show the relationship between presence of diabetic gastroparesis and demographic features, symptom severity, quality of life. Patients and Method: Patients with type 2 Diabetes Mellitus (DM) were enrolled in this study. Patients were interviewed face to face in terms of demographic profile, the Patient Assessment of Upper Gastrointestinal Disorder Symptoms (PAGI-SYM), and the Patient Assessment of Upper Gastrointestinal Disorders QOL (PAGI-QOL).Results: A total of 51 patients with type 2 DM were included in this study. The mean age of the type 2 DM patients without and with diabetic gastroparesis were respectively 53.35±6.98 and 57.04±9.41 (p=0.192). The most severe of symptoms based on PAG-SYM score was bloating in both patients with and without diabetic gastroparesis (2.69±2.21 and 2.57±2.22). In this study, nausea was correlated with poor quality of life based on PAGI-QOL but not with delayed gastric emptying (coef: 0.351, 95% CI: 0.035-0.667, P=0.030). Also, nausea score was correlated with impaired quality of life (coef: 0.207, 95% CI: 0.085-0.330, p<0.001). Both early satiation and early satiation score were significantly correlated with poor quality of life (coef: 1.061, %95CI:0.699-1.424, p<0.001 and coef:1.136, 95%CI:0.791-1.480, p<0.001) in our study.Conclusion: Early satiation and nausea are statistically significant independent predictors of poor quality of life in patients with Type 2 DM with and without diabetic gastroparesis. Also, nausea, abdominal pain, bloating and pyrosis were significantly associated with PAGI-SYM scores.